102 related articles for article (PubMed ID: 24149172)
1. (18)F-FDG PET/CT surveillance at 3-6 and 12 months for detection of recurrence and second primary cancer in patients with head and neck squamous cell carcinoma.
Kim JW; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Br J Cancer; 2013 Dec; 109(12):2973-9. PubMed ID: 24149172
[TBL] [Abstract][Full Text] [Related]
2. Screening for distant metastases in head and neck cancer patients using FDG-PET and chest CT: validation of an algorithm.
Senft A; Hoekstra OS; Witte BI; Leemans CR; de Bree R
Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2643-50. PubMed ID: 26350882
[TBL] [Abstract][Full Text] [Related]
3. Detection of synchronous cancers by fluorodeoxyglucose positron emission tomography/computed tomography during primary staging workup for esophageal squamous cell carcinoma in Taiwan.
Chen SH; Chan SC; Chao YK; Yen TC
PLoS One; 2013; 8(11):e82812. PubMed ID: 24312435
[TBL] [Abstract][Full Text] [Related]
4. Correlation of [
Pisani C; Vigna L; Mastroleo F; Loi G; Amisano V; Masini L; Deantonio L; Aluffi Valletti P; Sacchetti G; Krengli M
Radiat Oncol; 2021 Mar; 16(1):57. PubMed ID: 33743759
[TBL] [Abstract][Full Text] [Related]
5. Radiomics-based prediction of survival in patients with head and neck squamous cell carcinoma based on pre- and post-treatment
Liu Z; Cao Y; Diao W; Cheng Y; Jia Z; Peng X
Aging (Albany NY); 2020 Jul; 12(14):14593-14619. PubMed ID: 32674074
[TBL] [Abstract][Full Text] [Related]
6. The adverse impact of surveillance intervals on the sensitivity of FDG-PET/CT for the detection of distant metastases in head and neck cancer patients.
Senft A; Yildirim G; Hoekstra OS; Castelijns JA; René Leemans C; de Bree R
Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):1113-1120. PubMed ID: 27804082
[TBL] [Abstract][Full Text] [Related]
7. Routine surveillance scanning in HNSCC: Lung screening CT scans have value but head and neck scans do not.
Iovoli AJ; Platek AJ; Degraaff L; Wang C; Duncan WD; Wooten KE; Arshad H; Gupta V; Kuriakose MA; Hicks WL; Platek ME; Singh AK
Oral Oncol; 2018 Nov; 86():273-277. PubMed ID: 30409312
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced [18 F] fluorodeoxyglucose-positron emission tomography/computed tomography in clinical oncology: tumor-, site-, and question-based comparison with standard positron emission tomography/computed tomography.
Morbelli S; Conzi R; Campus C; Cittadini G; Bossert I; Massollo M; Fornarini G; Calamia I; Marini C; Fiz F; Ghersi C; Derchi LE; Sambuceti G
Cancer Imaging; 2014 Apr; 14(1):10. PubMed ID: 25609564
[TBL] [Abstract][Full Text] [Related]
9. Surveillance imaging for patients with head and neck cancer treated with definitive radiotherapy: A partially observed Markov decision process model.
Ng SP; Ajayi T; Schaefer AJ; Pollard C; Bahig H; Garden AS; Rosenthal DI; Gunn GB; Frank SJ; Phan J; Morrison WH; Johnson JM; Mohamed ASR; Sturgis EM; Fuller CD
Cancer; 2020 Feb; 126(4):749-756. PubMed ID: 31725906
[TBL] [Abstract][Full Text] [Related]
10. Imaging of the Posttreatment Head and Neck: Expected Findings and Potential Complications.
Brahmbhatt S; Overfield CJ; Rhyner PA; Bhatt AA
Radiol Imaging Cancer; 2024 Jan; 6(1):e230155. PubMed ID: 38276904
[TBL] [Abstract][Full Text] [Related]
11. Beyond the
Schöder H
AJR Am J Roentgenol; 2024 May; ():1. PubMed ID: 37729552
[No Abstract] [Full Text] [Related]
12. FDG PET/CT in the management of nasopharyngeal carcinoma.
Mohandas A; Marcus C; Kang H; Truong MT; Subramaniam RM
AJR Am J Roentgenol; 2014 Aug; 203(2):W146-57. PubMed ID: 25055290
[TBL] [Abstract][Full Text] [Related]
13. FDG volumetric parameters and survival outcomes after definitive chemoradiotherapy in patients with recurrent head and neck squamous cell carcinoma.
Paidpally V; Chirindel A; Chung CH; Richmon J; Koch W; Quon H; Subramaniam RM
AJR Am J Roentgenol; 2014 Aug; 203(2):W139-45. PubMed ID: 25055289
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of pretreatment 18F-FDG PET/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma.
Koyasu S; Nakamoto Y; Kikuchi M; Suzuki K; Hayashida K; Itoh K; Togashi K
AJR Am J Roentgenol; 2014 Apr; 202(4):851-8. PubMed ID: 24660716
[TBL] [Abstract][Full Text] [Related]
15. 18FDG PET-CT for distant metastases in patients with recurrent head and neck cancer after definitive treatment. A meta-analysis.
Gao S; Li S; Yang X; Tang Q
Oral Oncol; 2014 Mar; 50(3):163-7. PubMed ID: 24368204
[TBL] [Abstract][Full Text] [Related]
16. Post-treatment surveillance imaging in head and neck cancer: a systematic review.
Van Hoe S; Hermans R
Insights Imaging; 2024 Feb; 15(1):32. PubMed ID: 38315325
[TBL] [Abstract][Full Text] [Related]
17. An Intensive 18F-Fludeoxyglucose-Positron Emission Tomography With Computed Tomography-Based Strategy of Follow-Up in Patients Treated for Head and Neck Squamous Cell Carcinoma Who Are Clinically Asymptomatic.
Leclère JC; Clément C; Le Pennec R; Maheo C; Gujral DM; Schick U; Le Gal G; Marianowski R; Salaun PY; Abgral R
JAMA Netw Open; 2023 Aug; 6(8):e2326654. PubMed ID: 37526935
[TBL] [Abstract][Full Text] [Related]
18. Narrow Band Imaging Technology: Role in the Detection of Recurrent Laryngeal and Hypopharyngeal Cancers Post-radiotherapy.
Deva FAL
Indian J Otolaryngol Head Neck Surg; 2023 Jun; 75(2):753-759. PubMed ID: 37275073
[TBL] [Abstract][Full Text] [Related]
19. Towards reliable head and neck cancers locoregional recurrence prediction using delta-radiomics and learning with rejection option.
Wang K; Dohopolski M; Zhang Q; Sher D; Wang J
Med Phys; 2023 Apr; 50(4):2212-2223. PubMed ID: 36484346
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of a Decision Analytical Model for Posttreatment Surveillance for Patients With Oropharyngeal Carcinoma.
Nair V; Auger S; Kochanny S; Howard FM; Ginat D; Pasternak-Wise O; Juloori A; Koshy M; Izumchenko E; Agrawal N; Rosenberg A; Vokes EE; Skandari MR; Pearson AT
JAMA Netw Open; 2022 Apr; 5(4):e227240. PubMed ID: 35416988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
